The global parkinson’s disease therapeutic market is on a steady growth trajectory, with a projected market size of USD 4.3 billion in 2024. As advancements in medical research and technology continue to drive innovation, the market is expected to reach an estimated USD 6.7 billion by 2034, reflecting a compound annual growth rate (CAGR) of 5.1% over the next decade.
https://www.globenewswire.com/en/news-release/2024/08/28/2936843/0/en/Steady-Growth-Predicted-in-Parkinson-s-Disease-Therapeutic-Market-valuation-is-expected-to-be-USD-6-7-Billion-by-2034-and-is-estimated-to-be-5-1-with-Breakthroughs-in-Research-and-.html
https://www.globenewswire.com/en/news-release/2024/08/28/2936843/0/en/Steady-Growth-Predicted-in-Parkinson-s-Disease-Therapeutic-Market-valuation-is-expected-to-be-USD-6-7-Billion-by-2034-and-is-estimated-to-be-5-1-with-Breakthroughs-in-Research-and-.html
The global parkinson’s disease therapeutic market is on a steady growth trajectory, with a projected market size of USD 4.3 billion in 2024. As advancements in medical research and technology continue to drive innovation, the market is expected to reach an estimated USD 6.7 billion by 2034, reflecting a compound annual growth rate (CAGR) of 5.1% over the next decade.
https://www.globenewswire.com/en/news-release/2024/08/28/2936843/0/en/Steady-Growth-Predicted-in-Parkinson-s-Disease-Therapeutic-Market-valuation-is-expected-to-be-USD-6-7-Billion-by-2034-and-is-estimated-to-be-5-1-with-Breakthroughs-in-Research-and-.html
0 Comments
0 Shares
20 Views
0 Reviews